Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD
Not Applicable
Recruiting
- Conditions
- Non-Alcoholic Fatty Liver Disease
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 70
- Registration Number
- NCT06704321
- Locations
- 🇨🇦
Institut sur la nutrition et les aliments fonctionnels (INAF), Québec, Quebec, Canada
Effect of the Food Supplement TOTUM-070 on Lipid Metabolism
Not Applicable
Active, not recruiting
- Conditions
- Hypercholesterolemia
- Interventions
- Dietary Supplement: PLACEBODietary Supplement: TOTUM-070
- First Posted Date
- 2024-02-06
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 180
- Registration Number
- NCT06243484
- Locations
- 🇩🇪
Biotesys, Esslingen, Germany
Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption
Not Applicable
Completed
- Conditions
- Mild Inflammatory ContextNAFLDMASLD
- Interventions
- Dietary Supplement: TOTUM-448
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 10
- Registration Number
- NCT06047847
- Locations
- 🇫🇷
University Hospital Clermont-Ferrand, Clermont-Ferrand, France
Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio-metabolic Risk
Not Applicable
Terminated
- Conditions
- HypercholesterolemiaCardiovascular Risk FactorDyslipidemiasAtherosclerosisCardio-metabolic Risk
- Interventions
- Dietary Supplement: TOTUM-070
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 31
- Registration Number
- NCT05594979
- Locations
- 🇫🇷
CIC Clermont Ferrand, Clermont-Ferrand, France
Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
Not Applicable
Active, not recruiting
- Conditions
- Metabolic SyndromePrehypertensionElevated Blood PressureBlood Pressure
- Interventions
- Dietary Supplement: TOTUM-854Dietary Supplement: Placebo
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 410
- Registration Number
- NCT05469503
- Locations
- 🇵🇱
Centrum Medyczne Oporów, Wrocław, Poland
🇧🇬Diagnostic Consultative Center XX- Sofia EOOD, Sofia, Bulgaria
🇵🇱Vitamed Gałaj i Cichomski sp.j, Bydgoszcz, Poland
Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk
Not Applicable
Completed
- Conditions
- Prediabetic StateOverweight and ObesityDysglycemia
- Interventions
- Dietary Supplement: TOTUM-63
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 20
- Registration Number
- NCT05369585
- Locations
- 🇨🇦
Institute of Nutrition and Funtional Foods (INAF) - Laval University, Quebec, Canada
To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
Not Applicable
Recruiting
- Conditions
- Elevated Blood Pressure
- Interventions
- Dietary Supplement: Totum-854Dietary Supplement: Placebo
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 400
- Registration Number
- NCT05370625
- Locations
- 🇩🇪
BioTeSys, Esslingen, Germany
Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects
Not Applicable
Completed
- Conditions
- Cardiovascular Risk FactorAtherosclerosisHypercholesterolemiaOverweight and ObesityDyslipidemias
- Interventions
- Dietary Supplement: TOTUM-070Dietary Supplement: Placebo
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 120
- Registration Number
- NCT04760951
- Locations
- 🇫🇷
Biofortis Mérieux NutriSciences, Saint-Herblain, France
🇫🇷Institut Pasteur de Lille, Lille, France
🇩🇪Biotesys, Esslingen, Germany
Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)
Not Applicable
Completed
- Conditions
- Prediabetic StateDiabetes type2Dysglycemia
- Interventions
- Dietary Supplement: TOTUM-63 3 intakes per dayDietary Supplement: TOTUM-63 2 intakes per dayDietary Supplement: Placebo 3 intakes per day
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 636
- Registration Number
- NCT04423302
- Locations
- 🇧🇬
MHAT-Botevgrad EOOD, Botevgrad, Botevgrad, Bulgaria
🇧🇬MHAT Sveta Karidad, First department of Internal Diseases, Plovdiv, Bulgaria
🇧🇬4th Multiprofile Hospital for active treatment - EAD, Internal Diseases Departement, Sofia, Bulgaria
Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03)
Phase 1
Completed
- Conditions
- Obese
- Interventions
- Dietary Supplement: Lipidrive
- First Posted Date
- 2017-02-14
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 20
- Registration Number
- NCT03052062
- Locations
- 🇫🇷
Centre d'Investigation Clinique, Clermont-Ferrand, France
© Copyright 2025. All Rights Reserved by MedPath